Saba Capital Management, L.P. bought HQL
May 1, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 252 shares of Abrdn Life Sciences Investors at $13.02 per share, a transaction worth $3.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
252
Price
$13.02
Total value
$3.3K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 1, 2024
Filing dateMay 2, 2024
Shares owned after3,042,456
OwnershipIndirect
10b5-1 planNo
AmendedNo